Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873249 | 0.90 | TAAR1 (0.46) | L3MBTL1OPRM1OPRK1OPRD1RAB9A | |
| SCHEMBL7455241 | 0.90 | TAAR1 (0.46) | L3MBTL1OPRM1OPRK1OPRD1RAB9A | |
| SCHEMBL7458158 | 0.88 | OPRM1 (0.46) | OPRM1OPRK1OPRD1TAAR1HRH3 | |
| SCHEMBL27807030 | 0.80 | OPRM1 (0.57) | OPRM1OPRK1OPRD1TAAR1HRH3 | |
| SCHEMBL5722220 | 0.80 | ACHE (0.49) | OPRM1OPRK1OPRD1RAB9AHSD17B3 | |
| SCHEMBL15186465 | 0.79 | OPRM1 (0.52) | OPRM1OPRK1OPRD1TAAR1HRH3 | |
| SCHEMBL6527498 | 0.78 | MEN1 (0.39) | OPRM1HRH3MEN1KMT2A | |
| SCHEMBL21535464 | 0.78 | OPRM1 (0.59) | OPRM1OPRK1OPRD1HRH3MEN1 | |
| SCHEMBL20197002 | 0.78 | OPRM1 (0.40) | L3MBTL1OPRM1OPRK1OPRD1TAAR1 | |
| SCHEMBL10984795 | 0.78 | OPRM1 (0.45) | L3MBTL1OPRM1OPRK1OPRD1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3596195-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | The Procter and Gamble Company (US) | 2020-01-22 | — | — | EP | disclosed |
| EP-3596192-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | The Procter and Gamble Company (US) | 2020-01-22 | — | — | EP | disclosed |
| WO-2018169532-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2018169531-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | THE PROCTER & GAMBLE COMPANY (US) | 2018-09-20 | — | — | WO | disclosed |
| WO-2017158497-A1 | HYDROPHOBICALLY MODIFIED UREA ETHERS AS STRUCTURANTS FOR HYDROPHOBIC SYSTEMS | PROCTER & GAMBLE INERNATIONAL OPERATIONS SA (CH) | 2017-09-21 | — | — | WO | disclosed |
| EP-2741731-A1 | ENCAPSULATES | The Procter and Gamble Company (US) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| EP-2512406-A1 | PERFUMES AND PERFUME ENCAPSULATES | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2513280-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012085864-A1 | ENCAPSULATES | PROCTER & GAMBLE INTERNATIONAL OPERATIONS SA (CH) | 2012-06-28 | — | — | WO | disclosed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |